A- A A+

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

Neale et al. 

Harm Reduction Journal (2019) 16:25, doi.org/10.1186/s12954-019-0296-4

https://link.springer.com/epdf/10.1186/s12954-019-0296-4